Trust Center

active-control

AI & Enterprise Governance

Make every AI asset, workflow, decision boundary, owner, evidence source, and human approval inspectable.

OwnerExecutive, clinical, security, privacy, and AI governance
Requirements4
Active controls3
Decisions / external1 / 0

Current posture

Agent registry, TrustQA, Trust Cards, AI Asset Registry, audit surfaces, human approvals, deny-by-default routes, and quality gates are active for synthetic evaluation.

Public commitments

  • Require accountable ownership and human review.
  • Attach provenance, confidence, validation, and boundaries to recommendations.
  • Measure workflow outcomes and override behavior, not benchmark scores alone.

Control register

Evidence, required actions, and launch gates stay linked.

active-control

AI Asset Registry and shadow-AI control

Atlas and Audit surfaces expose AI assets, owners, usage boundaries, and shadow-AI detection posture.

Require registration and approval before every model, prompt, agent, connector, tool, and knowledge source enters a workflow.
  • Owner: AI governance
  • Launch gate: Required before evaluation or production use.
decision-required

Accountable owners and decision rights

Product registers identify owners and review roles at a control level.

Approve enterprise RACI, risk acceptance authority, clinical safety ownership, escalation, and board reporting.
  • Owner: Executive leadership
  • Launch gate: Required before protected pilots.
active-control

Human oversight and override

Current agents and workflows remain human-review gated with blocked unsafe actions.

Define reviewer competence, approval authority, override evidence, escalation, and monitoring per workflow.
  • Owner: Product and workflow owners
  • Launch gate: Required before every pilot and production workflow.
active-control

Continuous validation and change control

Synthetic validations, conformance kits, fixture fingerprints, promotion reviews, proof routes, and outcome metrics are inspectable.

Bind production changes to versioned approvals, monitored outcomes, incident thresholds, and rollback decisions.
  • Owner: Quality, Watchtower, and product
  • Launch gate: Production promotion remains blocked until approved.

Prohibited actions

These actions remain blocked.

  • Deploying unregistered agents, models, prompts, or knowledge sources.
  • Allowing autonomous diagnosis, treatment, or patient-facing action.
  • Promoting a workflow without evidence, approval, monitoring, and rollback controls.

Authoritative references